July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Histopathological analysis of residual lens cells in capsular opacities after cataract surgery
Author Affiliations & Notes
  • Christina Mastromonaco
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Matthew Balazsi
    Medical Parachute, Montreal, Quebec, Canada
  • Ana Beatriz Toledo Dias
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Debra-Meghan Sanft
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Jade Marie Lasiste
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Alessio Cardillo
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Jose Joao Mansure
    McGill Urologic Oncology , Montreal, Quebec, Canada
  • Miguel N Burnier
    MUHC Ocular Pathology Laboratory , Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships   Christina Mastromonaco, None; Matthew Balazsi, Medical Parachute (P), Medical Parachute (I); Ana Beatriz Dias, None; Debra-Meghan Sanft, None; Jade Lasiste, None; Alessio Cardillo, None; Jose Mansure, None; Miguel Burnier, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6015. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christina Mastromonaco, Matthew Balazsi, Ana Beatriz Toledo Dias, Debra-Meghan Sanft, Jade Marie Lasiste, Alessio Cardillo, Jose Joao Mansure, Miguel N Burnier; Histopathological analysis of residual lens cells in capsular opacities after cataract surgery. Invest. Ophthalmol. Vis. Sci. 2018;59(9):6015.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Posterior capsular opacification (PCO) is the leading long-term complication of cataract surgery caused by the remnant lens epithelial cells (LECs) within the capsular bag. LECs undergo epithelial-to-mesenchymal (EMT) transition and acquire a myofibroblast phenotype, further depositing extracellular matrix, such as fibronectin (FN), leading to opacities. Duration of IOL implant, patient comorbidities, and IOL type may be contributing factors to PCO. The aim of this study is to histopathologically analyze EMT and FN expression, and determine the factors that correlate with these changes.

Methods : In total, one hundred and nighty capsular bags with implanted IOLs were removed from formalin-fixed post-mortem eyes (Minnesota Eye Bank). Clinical history and IOL type were available. Digital images with the Olympus DSX 110 microscope were obtained and PCO was graded using previously published automated software (ADOS, Medical Parachute). After specimens were paraffin-embedded, automated immunohistochemistry with the Ventana Benchmark platform was performed using anti-Smooth Muscle Actin (SMA) to detect EMT, and anti-FN. Slides were digitized using the Aperio ScanScope Scanner, and analysed using the Positive Pixel Count v9 algorithm. Statistical analysis was performed using Spearman correlation, linear regression and one-way ANOVA; P<0.05 was considered significant.

Results : IOL implantation time and SMA expression had a significant negative correlation (P<0.0001, r=-0.068, r2=0.274). Patient age and SMA expression were also negatively correlated (P=0.0319, r=-0.271). SMA expression was higher within 4 years of IOL implantation and in younger patients. A significant difference between 5 IOL models and SMA expression (P=0.0380) was observed. Optic edge design and gender did not contribute to FN or SMA expression. No correlation between FN and SMA expression, or with the intensity of PCO, was noted.

Conclusions : This study demonstrated that EMT changes increase within the first few years after surgery. SMA expression is significantly different according to IOL type, thus indicating that LEC changes depend on the lens biocompatibility. Therefore, by analysing the histopathological composition of PCO using LECs, further insight into the characteristics of IOLs that are important for biocompatibility can be ascertained.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.